Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients (PERICO)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by Hospital Carlos III, Madrid.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Hospital Carlos III, Madrid
ClinicalTrials.gov Identifier:
NCT00526448
First received: September 5, 2007
Last updated: January 28, 2009
Last verified: January 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2010
  Estimated Primary Completion Date: No date given
No publications provided by Hospital Carlos III, Madrid

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):